Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 6,076 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

A robust method of nuclei isolation for single-cell RNA sequencing of solid plant tissues

Zymo Research releases bioinformatics pipeline for SARS-CoV-2 variant detection

Integrating barcoded neuroanatomy with spatial transcriptional profiling

Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targets

Performance assessment of sample-specific network control methods for bulk and single-cell biological data analysis

Single-nucleus RNA sequencing explains why some neurons are more susceptible than others in Alzheimer’s disease

RNA-Seq data suggests that exitron splicing represents an additional cancer-driving mechanism beyond genetic alterations